{"slideshow_credits": null, "snippet": "The product, called Afrezza, would offer people with diabetes a treatment option that does not require injections, although its success in clinical trials has been modest at best.", "abstract": "Government advisory committee recommends that Food and Drug Administration approve form of insulin that is inhaled rather than injected; suggest that product, called Afrezza and developed by MannKind Corporation, will offer new treatment option for millions of Americans with diabetes.", "section_name": "Health", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/04/02/health/inhaled-insulin-clears-advisory-hurdle-toward-fda-approval.html", "lead_paragraph": "The product, called Afrezza, would offer people with diabetes a treatment option that does not require injections, although its success in clinical trials has been modest at best.", "headline": {"main": "Inhaled Insulin Clears Hurdle Toward F.D.A. Approval", "print_headline": "Inhaled Insulin Clears Hurdle Toward F.D.A. Approval"}, "_id": "533b419b38f0d811da910807", "word_count": "850", "multimedia": [{"height": 126, "url": "images/2014/04/02/business/INHALE/INHALE-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/04/02/business/INHALE/INHALE-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 476, "url": "images/2014/04/02/business/INHALE/INHALE-articleLarge.jpg", "legacy": {"xlarge": "images/2014/04/02/business/INHALE/INHALE-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "476"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/04/02/business/INHALE/INHALE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/04/02/business/INHALE/INHALE-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-04-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Diabetes", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "MannKind Corporation", "name": "organizations", "is_major": "Y", "rank": "7"}, {"value": "Medicine and Health", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Insulin", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Regulation and Deregulation of Industry", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}